Short-term efficacy and safety of new biological agents targeting the interleukin-23–T helper 17 pathway for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis

JUAN ALBERTO RUANO RUIZJUAN ALBERTO RUANO RUIZ2026-01-292026-01-29201710.1111/bjd.148142-s2.0-84995493600https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27596DermatologyShort-term efficacy and safety of new biological agents targeting the interleukin-23–T helper 17 pathway for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysisreview article